Provided by Tiger Trade Technology Pte. Ltd.

Corgi NVO 2x Daily ETF

13.96
-0.4353-3.02%
Volume:1K
Turnover:15.49K
Market Cap:209.33K
PE:- -
High:13.96
Open:13.96
Low:13.96
Close:14.39
52wk High:27.19
52wk Low:13.75
Shares:15.00K
Float Shares:15.00K
Volume Ratio:55.35
T/O Rate:7.40%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

NYSE Net Change Percentage Gainers & Losers

Dow Jones
·
Sep 22

NYSE Most Active Issues

Dow Jones
·
Sep 22

Exchange Traded Funds Top 10 Percentage Losers

Dow Jones
·
Sep 22

European Stocks Close Higher Monday as Oil Prices Tumble

MT Newswires Live
·
Sep 22

Novo Nordisk A/S Series B Stock Falls Monday, Underperforms Market

Dow Jones
·
Sep 22

Top Midday Stories: Paramount Skydance Settles With US States to Pave Way for Warner Bros. Deal; Anthropic Now Eyeing November IPO

MT Newswires Live
·
Sep 21

Weight-Loss Drug Giant Sheds 13,000 Positions

Deep News
·
Sep 21

Novo Nordisk Details Progress on DKK 15 Billion Share Buyback Programme

TIPRANKS
·
Sep 21

European Equities Traded in the US as American depositary Receipts Rise in Monday Trading

MT Newswires Live
·
Sep 21

Cboe data shows mixed options sentiment in Novo Nordisk with shares down 7.85%

TIPRANKS
·
Sep 21

Novo Nordisk Says New Obesity Drug Outperformed Lilly's Zepbound in Phase 3 Trial

Dow Jones
·
Sep 21

Novo Nordisk A/S Stock (NVO) Moved Down by 7.86% on Sep 21: A Full Analysis

TradingKey
·
Sep 21

Novo Stock (NVO) Sinks Despite Beating Eli Lilly in New CagriSema Obesity Trial

TIPRANKS
·
Sep 21

Sector Update: Healthcare

MT Newswires Live
·
Sep 21

Update: Oil Price Decline Lifts US Equity Futures Pre-Bell

MT Newswires Live
·
Sep 21

Why Novo Stock is Dropping After Drugmaker Unveils Ambitious Growth Plan

Dow Jones
·
Sep 21

【US Pre-Market】US-China Talks Boost Markets, Bitcoin Rises to $85,000, Greenland Concept Stocks Surge, Oil Falls for Fourth Day

TradingKey
·
Sep 21

Novo Nordisk's Weight-Loss, Diabetes Drug Candidate Meets Primary Goals

MT Newswires Live
·
Sep 21

Goldman Sachs Sticks to Their Hold Rating for Novo Nordisk (0QIU)

TIPRANKS
·
Sep 21

Novo Says Its Next-Gen Obesity Drug Tops Lilly Rival in Late-Stage Study

Reuters
·
Sep 21